Terns Pharmaceuticals to Host Conference Call to Discuss
FOSTER CITY, Calif., June 13, 2021 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule single-agent and combination …